155 related articles for article (PubMed ID: 22248134)
1. Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck..
Kaye S
Addiction; 2012 Feb; 107(2):251-3. PubMed ID: 22248134
[No Abstract] [Full Text] [Related]
2. Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction?
Ambermoon P; Carter A; Hall W; Dissanayaka N; O'Sullivan J
Addiction; 2012 Feb; 107(2):241-7. PubMed ID: 21793971
[TBL] [Abstract][Full Text] [Related]
3. Compulsive use of dopamine replacement therapy in Parkinson's disease: insights into the neurobiology of addiction.
Brown RM; Lawrence AJ
Addiction; 2012 Feb; 107(2):250-1. PubMed ID: 22248133
[No Abstract] [Full Text] [Related]
4. Addiction as aberrant learning-evidence from Parkinson's disease.
Dagher A
Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
[No Abstract] [Full Text] [Related]
5. Dopamine is not dopamine.
Soyka M
Addiction; 2012 Feb; 107(2):248. PubMed ID: 22248131
[No Abstract] [Full Text] [Related]
6. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
7. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
[TBL] [Abstract][Full Text] [Related]
8. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs.
Poletti M; Logi C; Lucetti C; Del Dotto P; Baldacci F; Vergallo A; Ulivi M; Del Sarto S; Rossi G; Ceravolo R; Bonuccelli U
J Clin Psychopharmacol; 2013 Oct; 33(5):691-4. PubMed ID: 23857310
[TBL] [Abstract][Full Text] [Related]
9. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
Kimber TE; Thompson PD; Kiley MA
J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
[TBL] [Abstract][Full Text] [Related]
10. [Impulse control disorders in Parkinson's disease].
Joutsa J; Kaasinen V
Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
[TBL] [Abstract][Full Text] [Related]
11. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
12. Medication-related impulse control and repetitive behaviors in Parkinson disease.
Voon V; Fox SH
Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
[TBL] [Abstract][Full Text] [Related]
13. Compulsive singing: another aspect of punding in Parkinson's disease.
Bonvin C; Horvath J; Christe B; Landis T; Burkhard PR
Ann Neurol; 2007 Nov; 62(5):525-8. PubMed ID: 17696122
[TBL] [Abstract][Full Text] [Related]
14. Drugs can trigger pathological gambling.
Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985369
[TBL] [Abstract][Full Text] [Related]
15. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
16. Three cases of impulse control disorder in Parkinson's disease patients receiving dopamine replacement therapy.
Wilson L; Sheehan J; Thorpe M
Ir Med J; 2013 Jan; 106(1):24-5. PubMed ID: 23472375
[TBL] [Abstract][Full Text] [Related]
17. A case of hedonistic homeostatic dysregulation.
Kessel BL
Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic dysregulation syndrome in Parkinson's disease.
Katzenschlager R
J Neurol Sci; 2011 Nov; 310(1-2):271-5. PubMed ID: 21868039
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced impulse control disorders in Parkinson's disease.
Reiff J; Jost WH
J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
[TBL] [Abstract][Full Text] [Related]
20. Multiple impulse control disorders developing in Parkinson's disease after initiation of amantadine.
Walsh RA; Lang AE
Mov Disord; 2012 Feb; 27(2):326. PubMed ID: 21954056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
